Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Press Releases

IAVI and WomenLift Health announce partnership to promote women’s leadership in global health

February 27, 2024

Memorandum of understanding targets gender equity, mentorship, and training to expand the power and influence of talented women in science.

Read more

Press Releases

ReiThera Srl, the Ragon Institute and IAVI announce collaboration to advance highly networked T-cell HIV vaccine candidate towards Phase 1 clinical evaluation 

January 22, 2024

Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by the Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to prevention options.

Read more

Press Releases

IAVI and Zendal announce funding for efficacy trial of promising TB vaccine candidate in Africa

December 18, 2023

TB kills 1.3 million people a year and sickens more than 10 million people annually. A new TB vaccine is needed to reach the global End TB goals. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB…

Read more

Press Releases

Japan’s National Institute of Infectious Diseases and IAVI announce partnership to accelerate global translational research for infectious diseases

October 13, 2023

NEW YORK and TOKYO — October 13, 2023 — IAVI, a nonprofit scientific research organization, and Japan’s National Institute of Infectious Diseases (NIID), the primary infectious disease research institute funded by the Government of Japan, have signed a memorandum of understanding to strengthen their international cooperation for research and development (R&D) to control infectious diseases. Two…

Read more

Press Releases

Germany issues award to IAVI to support development of the MTBVAC tuberculosis vaccine candidate

July 6, 2023

NEW YORK — JULY 6, 2023 — IAVI is pleased to announce a new award has been granted by the German government to help support the late-stage development of a promising tuberculosis (TB) vaccine candidate, MTBVAC. The German Federal Ministry of Education and Research (BMBF) through the KfW Development Bank has committed to contribute €9.2…

Read more

Press Releases

IAVI launches multisite study with adolescent girls and young women to evaluate vaccine and antibody candidates for HIV prevention in sub-Saharan Africa

June 30, 2023

First participants for the Multisite Adolescent Girls and Young Women study screened at the Centre for Family Health Research in Zambia. IAVI has announced the enrolment of the first 29 participants for the Multisite Adolescent Girls and Young Women (MAGY) study at the Centre for Family Health Research in Zambia (CFHRZ). Over the next three…

Read more

Press Releases

IAVI starts first-in-human Phase 1 clinical trial of single-dose Sudan virus vaccine candidate

June 27, 2023

NEW YORK – JUNE 27, 2023 – IAVI announced today that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase 1 clinical trial in the U.S. The IAVI-sponsored trial is funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness…

Read more

Press Releases

Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

May 16, 2023

TB kills 1.6 million people a year, causing more deaths than any other single infectious disease apart from COVID-19, and sickens more than 10 million people annually. A new TB vaccine is needed to reach global END TB goals. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an…

Read more